The Prevention of Pancreatitis after Endoscopic Papillectomy; Stent versus No Stent.
10.15279/kpba.2016.21.1.19
- Author:
Chang Min CHO
1
Author Information
1. Department of Internal Medicine, Kyungpook National University College of Medicine, Daegu, Korea. cmcho@knu.ac.kr
- Publication Type:Review
- Keywords:
Endoscopic papillectomy;
Ampullary adenoma;
Pancreatitis;
Pancreatic stent
- MeSH:
Adenoma;
Cholangiopancreatography, Endoscopic Retrograde;
Humans;
Pancreatitis*;
Prevalence;
Prospective Studies;
Stents*
- From:Korean Journal of Pancreas and Biliary Tract
2016;21(1):19-23
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Endoscopic papillectomy (EP) has been considered to be a less invasive, alternative therapy to surgery for ampullary adenoma. However, complication rates after EP could not be ignored, when compared to endoscopic resection for gastrointestinal lesions. Among them, the prevalence of postpapillectomy pancreatitis is higher in EP than ERCP. The prophylactic placement of a pancreatic stent has been reported to decrease the risk of pancreatitis after EP. However, since pancreatic stent placement after EP is not always successful, various novel techniques have been developed to ensure reliable stent placement. Despite the recent advances in EP, a prospective, randomized, controlled study with a larger number of patients is needed to assess the efficacy of pancreatic stent placement to prevent pancreatitis.
